Entering text into the input field will update the search result below

Profound Medical Corp. (PROF) CEO Arun Menawat on Q4 2020 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Profound Medical Corp. (NASDAQ:PROF) Q4 2020 Earnings Conference Call March 2, 2021 4:30 PM ET

Company Participants

Stephen Kilmer - IR

Arun Menawat - CEO

Aaron Davidson - CFO and SVP, Corporate Development

Conference Call Participants

Anthony Petron - Jefferies

Rahul Sarugaser - Raymond James

Frank Takkinen - Lake Street Capital

Ben Haynor - Alliance Global

Michael Bunyaner - TLF Capital


Ladies and gentlemen, thank you for standing by and welcome to the Profound Medical Fourth Quarter and Full Year 2020 Financial Results Conference Call. [Operator Instructions] And please be advised that today’s conference is being recorded.

Now I would like to turn the conference over to your speaker today Stephen Kilmer with Investor Relations.

Stephen Kilmer

Thank you. Good afternoon everyone. Let me start by pointing out that this conference call will include forward-looking statements regarding Profound and its business, which may include, but is not limited to, expectations regarding the efficacy of Profound’s technology in the treatment of prostate cancer, BPH, uterine fibroids and palliative pain and osteoid osteoma.

Often, but not always, forward-looking statements can be identified by the use of words such as plans, as expected, expects, scheduled, intends, contemplates, anticipates, believes, proposes or variations including negative variations of such words and phrases or states that certain actions, events or results may, could, would, might, will, be taken, occur or be achieved. Such statements are based on the current expectations of management.

The forward-looking events and circumstances discussed in this conference call may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the company, including risks regarding the medical device industry, economic factors, the equity markets generally and risks associated with growth and competition.

Although Profound has attempted to

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.